Why the study?
This study aimed to investigate the effect of weight change, including weight gain and loss, on microvascular and macrovascular complications in patients with type 2 diabetes mellitus.
Does weight change (gain or loss) affect the risk of microvascular and macrovascular complications and mortality in patients with type 2 diabetes mellitus?
Does weight change (gain or loss) affect the risk of microvascular and macrovascular complications and mortality in patients with type 2 diabetes mellitus?
In patients with type 2 diabetes, both weight loss and weight gain are associated with adverse outcomes, though weight loss carries a higher risk of mortality and cardiovascular complications compared to weight gain, underscoring the benefit of maintaining a stable, healthy weight.
Answers are grounded in this paper and cite their sources.
Weight management in T2DM requires individualized caution on CVD risk; leaves open need for prospective trials to clarify targets.
Type 2 diabetes mellitus (T2DM) is a metabolic disease that can be a significant cause of cardiovascular disease (CVD), leading to macrovascular and microvascular diseases. Many researchers around the world have investigated the effects of weight change on micro and macro CVD in patients with T2DM. This study aimed to investigate the effect of weight change (weight gain and loss) on microvascular and macrovascular complications in patients with T2DM. We searched PubMed, Scopus and Google Scholar from the database until January 2023. We screened the title, abstract, and full text of articles, and after quality assessment, we extracted data from interrelated ones into this systematic review. Reviewing the results of 11 cohort studies with 219,839 individuals (T2DM patients) showed that weight loss caused an increase in the mortality rate in diabetic patients, while weight gain after diabetes diagnosis increased the risk of CVD, chronic kidney disease (CKD), microvascular disease, stroke and mortality. It should be noted that severe body weight variability increases the mortality rate and the risk of microvascular disease. Unlike other studies, one study showed that more than 5% weight gain positively affected CVD and coronary heart disease in T2DM patients. Generally, weight change in patients with T2DM is an essential sign of cardiovascular complications. According to our findings, the risk of cardiovascular complications in patients with weight loss is seen to be higher than in patients with weight gain. In regular patients with body mass index (BMI), stable weight in a healthy range is reported to decrease the risk of CVD.
No takes yet. Share an insight, caveat, or question.
Rafiei et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: